Lawmakers in New Hampshire advanced a bill Friday that would make releasing large numbers of balloons a crime.
BMO Capital lowered the firm’s price target on Morningstar (MORN) to $370 from $387 but keeps an Outperform rating on the shares. The ...
Kiniksa (NASDAQ:KNSA) plans to initiate a Phase 2/3 clinical study of KPL-387 in recurrent pericarditis in mid-2025, with Phase 2 data expected in the second half of 2026.It added that Phase 1 ...
Kiniksa shifts focus to cardiovascular indications, halts abiprubart in Sjögren's, ends its AstraZeneca deal, and advances ...